Compare · BOOM vs EW
BOOM vs EW
Side-by-side comparison of DMC Global Inc. (BOOM) and Edwards Lifesciences Corporation (EW): market cap, price performance, sector, and recent activity on the wire.
Summary
- BOOM operates in Industrials, while EW operates in Health Care - the two are in different parts of the market.
- EW is the larger of the two at $49.52B, about 360.5x BOOM ($137.3M).
- Over the past year, BOOM is down 4.4% and EW is up 12.3% - EW leads by 16.7 points.
- EW has been more active in the news (14 items in the past 4 weeks vs 11 for BOOM).
- EW has more recent analyst coverage (25 ratings vs 6 for BOOM).
- Company
- DMC Global Inc.
- Edwards Lifesciences Corporation
- Price
- $6.74+0.00%
- $87.43+1.65%
- Market cap
- $137.3M
- $49.52B
- 1M return
- -11.66%
- +5.43%
- 1Y return
- -4.40%
- +12.26%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 11
- 14
- Recent ratings
- 6
- 25
DMC Global Inc.
DMC Global Inc. provides a suite of technical products for the energy, industrial, and infrastructure markets worldwide. The company operates in two segments, NobelClad and DynaEnergetics. Its NobelClad segment produces and sells explosion-welded clad metal plates for use in the construction of heavy, corrosion resistant pressure vessels, and heat exchangers for oil and gas, chemical and petrochemical, alternative energy, hydrometallurgy, aluminum production, shipbuilding, power generation, and industrial refrigeration industries. The company sells its products through direct sales personnel, program managers, and independent sales representatives. Its DynaEnergetics segment designs, manufactures, markets, and sells perforating systems, including initiation systems, shaped charges, detonating cords, gun hardware, and control panels; and associated hardware for the oil and gas industry. It sells its products through direct selling, distributors, and independent sales representatives. The company was formerly known as Dynamic Materials Corporation and changed its name to DMC Global Inc. in November 2016. DMC Global Inc. was founded in 1965 and is headquartered in Broomfield, Colorado.
Edwards Lifesciences Corporation
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Latest BOOM
- SEC Form SD filed by DMC Global Inc.
- Chief Accounting Officer Seger Brett A. covered exercise/tax liability with 230 shares, decreasing direct ownership by 1% to 21,408 units (SEC Form 4) (tax withholding)
- Director Kelly Michael Aaron was granted 16,937 shares, increasing direct ownership by 35% to 65,590 units (SEC Form 4)
- Director Dreessen Ruth was granted 16,937 shares, increasing direct ownership by 35% to 65,283 units (SEC Form 4)
- Director Doubman John R was granted 16,937 shares, increasing direct ownership by 117% to 31,396 units (SEC Form 4)
- Director Sananikone Ouma was granted 16,937 shares, increasing direct ownership by 47% to 52,773 units (SEC Form 4)
- Director Spurlin Sharon was granted 16,937 shares, increasing direct ownership by 175% to 26,596 units (SEC Form 4)
- Chief Financial Officer Walter Eric V. covered exercise/tax liability with 11,427 shares, decreasing direct ownership by 11% to 88,603 units (SEC Form 4) to satisfy withholding tax
- DMC Global Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- SEC Form S-8 filed by DMC Global Inc.
Latest EW
- SEC Form 3 filed by new insider Mistras Theodora
- SVP, Corporate Controller Dahl Andrew M. sold $48,853 worth of shares (568 units at $86.08), decreasing direct ownership by 4% to 15,334 units (SEC Form 4)
- CVP,Strategy/Corp Development Bobo Donald E Jr sold $2,000,193 worth of shares (23,145 units at $86.42) (SEC Form 4)
- SEC Form SD filed by Edwards Lifesciences Corporation
- CVP, TMTT & Surgical Chopra Daveen sold $126,905 worth of shares (1,500 units at $84.60), decreasing direct ownership by 3% to 44,324 units (SEC Form 4)
- CVP, TAVR Lippis Daniel J. exercised 620 shares at a strike of $72.68 and sold $50,307 worth of shares (620 units at $81.14) as part of a pre-agreed trading plan (SEC Form 4)
- CVP,Strategy/Corp Development Bobo Donald E Jr sold $1,472,678 worth of shares (17,968 units at $81.96), decreasing direct ownership by 30% to 22,798 units (SEC Form 4)
- CEO Zovighian Bernard J converted options into 47,207 shares, covered exercise/tax liability with 26,198 shares, gifted 26,640 shares, received a gift of 26,640 shares and sold $2,833,013 worth of shares (36,351 units at $77.93) as part of a pre-agreed trading plan, decreasing direct ownership by 10% to 99,165 units (SEC Form 4)
- CVP,Strategy/Corp Development Bobo Donald E Jr converted options into 13,457 shares and covered exercise/tax liability with 7,469 shares, increasing direct ownership by 22% to 32,766 units (SEC Form 4)
- CVP, TMTT & Surgical Chopra Daveen converted options into 13,583 shares and covered exercise/tax liability with 7,538 shares, increasing direct ownership by 15% to 45,824 units (SEC Form 4)